Lawmakers allocated $6 billion this fiscal year for PEPFAR, the H.I.V. prevention and treatment program, but the administration has indicated it will release less than half of that.
Tag: Acquired Immune Deficiency Syndrome
Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support
A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much of the funding for that effort is gone.
Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support
A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much of the funding for that effort is gone.
Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support
A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much of the funding for that effort is gone.
South Africa Built a Medical Research Powerhouse. Trump Cuts Have Demolished It.
The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug companies, too.
Used in Covid Shots, mRNA May Help Rid the Body of H.I.V.
A new study shows how the technology deployed in Covid vaccines helped scientists coax the virus out of hiding.
Trump Budget Eliminates Funding for Crucial Global Vaccination Programs
The spending proposal terminates support of health programs that, according to the proposal, “do not make Americans safer.”
For John Green, It’s Tuberculosis All the Way Down
The best-selling author “got a little emotional” while talking with The Times about tuberculosis. Listen to the conversation.
Africa Received Billions in U.S. Aid. Here’s What It Will Lose.
The United States spent decades responding to conflicts and disease in Africa. The continent is now expected to be the hardest hit by the Trump administration’s aid cuts.
U.S. Terminates Funding for Polio, H.I.V., Malaria and Nutrition Programs Around the World
Here are some of the 5,800 contracts the Trump administration formally canceled this week in a wave of terse emails.